Conversely, the expression of KYNU, AOX1, KMO, TDO2, ACAT1, DDC, CYPIAI, OGDHL, WASRS1, AFMID, CYP1A2, ASMT, and TPH2 was lower in glioma than normal brain tissue samples. Here, KMO is linked to central nervous system cancer.